PE20071137A1 - Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianos - Google Patents
Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianosInfo
- Publication number
- PE20071137A1 PE20071137A1 PE2006001657A PE2006001657A PE20071137A1 PE 20071137 A1 PE20071137 A1 PE 20071137A1 PE 2006001657 A PE2006001657 A PE 2006001657A PE 2006001657 A PE2006001657 A PE 2006001657A PE 20071137 A1 PE20071137 A1 PE 20071137A1
- Authority
- PE
- Peru
- Prior art keywords
- antibacterial agents
- spiropyrimidintriona
- oxaquinoline
- piracin
- derivatives
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75326205P | 2005-12-22 | 2005-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20071137A1 true PE20071137A1 (es) | 2008-01-10 |
Family
ID=37872452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006001657A PE20071137A1 (es) | 2005-12-22 | 2006-12-20 | Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianos |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7557100B2 (enExample) |
| EP (2) | EP2620439A1 (enExample) |
| JP (1) | JP5513743B2 (enExample) |
| AR (1) | AR058701A1 (enExample) |
| CA (1) | CA2634644A1 (enExample) |
| DO (1) | DOP2006000268A (enExample) |
| GT (1) | GT200600520A (enExample) |
| NL (1) | NL2000373C2 (enExample) |
| PE (1) | PE20071137A1 (enExample) |
| TW (1) | TW200734344A (enExample) |
| UY (1) | UY30030A1 (enExample) |
| WO (1) | WO2007072151A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7601695B2 (en) | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
| DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
| RU2010103101A (ru) * | 2007-07-02 | 2011-08-10 | Астразенека Аб (Se) | Химические соединения |
| ATE523592T1 (de) * | 2007-07-06 | 2011-09-15 | Univ Aarhus | Dehydratisierte chitosan-nanopartikel |
| US20110178064A1 (en) | 2007-07-16 | 2011-07-21 | Astrazeneca R&D | Spiro condensed barbituric acid derivatives for use as antibacterial |
| AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| TW201020258A (en) * | 2008-10-14 | 2010-06-01 | Astrazeneca Ab | Chemical compounds 542 |
| CN107854477A (zh) | 2008-10-24 | 2018-03-30 | 森普拉制药公司 | 使用含三唑的大环内酯治疗抗性疾病的方法 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| US9480679B2 (en) | 2009-09-10 | 2016-11-01 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
| HRP20160168T1 (hr) | 2010-03-22 | 2016-03-25 | Cempra Pharmaceuticals Inc | Kristalne forme makrolida i njihova uporaba |
| BR112012029586A2 (pt) | 2010-05-20 | 2016-08-02 | Cempra Pharmaceuticals Inc | processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos |
| KR20130120458A (ko) | 2010-09-10 | 2013-11-04 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
| WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US8889671B2 (en) | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
| WO2014152326A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| AU2014233240B2 (en) | 2013-03-15 | 2018-08-09 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
| SG11201609404SA (en) | 2014-05-29 | 2016-12-29 | Entasis Therapeutics Ltd | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| UY36851A (es) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
| IL317854A (en) | 2017-07-28 | 2025-02-01 | Takeda Pharmaceuticals Co | TYK2 inhibitors and their uses |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011860A (en) * | 1986-04-11 | 1991-04-30 | Schering Corporation | Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases |
| DE19502178A1 (de) * | 1994-01-27 | 1995-08-03 | Hoechst Ag | Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen |
| US6608081B2 (en) * | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| CZ20031083A3 (cs) | 2000-10-26 | 2004-03-17 | Pfizer Products Inc. | 5-Spiropyrimidin-2, 4, 6-trionové inhibitory metaloproteinasy |
| BR0210099A (pt) * | 2001-05-30 | 2004-04-13 | Warner Lambert Co | Agentes antibacterianos |
| AU2003228701A1 (en) | 2002-04-25 | 2003-11-10 | Bristol-Myers Squibb Company | Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| CA2606847A1 (en) | 2005-05-09 | 2006-11-16 | Warner-Lambert Company Llc | Antibacterial agents |
| DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
-
2006
- 2006-11-29 DO DO2006000268A patent/DOP2006000268A/es unknown
- 2006-12-11 EP EP13151044.8A patent/EP2620439A1/en not_active Withdrawn
- 2006-12-11 EP EP06831728A patent/EP1971612A1/en not_active Withdrawn
- 2006-12-11 JP JP2008546665A patent/JP5513743B2/ja not_active Expired - Fee Related
- 2006-12-11 WO PCT/IB2006/003641 patent/WO2007072151A1/en not_active Ceased
- 2006-12-11 CA CA002634644A patent/CA2634644A1/en not_active Abandoned
- 2006-12-13 NL NL2000373A patent/NL2000373C2/nl not_active IP Right Cessation
- 2006-12-19 US US11/641,215 patent/US7557100B2/en not_active Expired - Fee Related
- 2006-12-19 UY UY30030A patent/UY30030A1/es not_active Application Discontinuation
- 2006-12-20 GT GT200600520A patent/GT200600520A/es unknown
- 2006-12-20 AR ARP060105669A patent/AR058701A1/es unknown
- 2006-12-20 PE PE2006001657A patent/PE20071137A1/es not_active Application Discontinuation
- 2006-12-21 TW TW095148255A patent/TW200734344A/zh unknown
-
2009
- 2009-07-15 US US12/503,123 patent/US20090275536A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007072151A1 (en) | 2007-06-28 |
| UY30030A1 (es) | 2007-07-31 |
| JP5513743B2 (ja) | 2014-06-04 |
| JP2009520804A (ja) | 2009-05-28 |
| US20090275536A1 (en) | 2009-11-05 |
| NL2000373A1 (nl) | 2007-06-26 |
| AR058701A1 (es) | 2008-02-20 |
| TW200734344A (en) | 2007-09-16 |
| CA2634644A1 (en) | 2007-06-28 |
| US7557100B2 (en) | 2009-07-07 |
| NL2000373C2 (nl) | 2010-02-02 |
| US20070197518A1 (en) | 2007-08-23 |
| GT200600520A (es) | 2007-07-17 |
| EP1971612A1 (en) | 2008-09-24 |
| EP2620439A1 (en) | 2013-07-31 |
| DOP2006000268A (es) | 2007-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20010544A1 (es) | Derivados de mutilina utiles como agentes antibacterianos | |
| PE20060555A1 (es) | Derivados de pirrol-oxindol como moduladores del receptor de progesterona | |
| PE20081583A1 (es) | Agentes antibacterianos derivados de compuestos carbonilamino | |
| SV2008002969A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| BR0017026A (pt) | Lipeptìdeos como agentes antibacterianos | |
| BRPI0412659A (pt) | isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto | |
| AUPR213700A0 (en) | Antiviral agents | |
| SE9904508D0 (sv) | New compounds | |
| PE20030431A1 (es) | DERIVADOS QUINUCLIDINAS COMO AGONISTAS DEL RECEPTOR NICOTINICO DE LA ACETILCOLINA TIPO a7 | |
| CO5700829A2 (es) | Derivados triciclicos de indol y su uso en eltratamiento de la enfermedad de alzheimer | |
| PE20070793A1 (es) | Compuestos triciclicos que contienen nitrogeno como agentes antibacterianos | |
| BR0002936A (pt) | Compostos de biciclicarbonil-indol como agentes antiinflamatórios/analgésicos | |
| PE20081831A1 (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
| DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| CL2011000784A1 (es) | Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales. | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| PE20090110A1 (es) | Compuestos macrociclicos derivados de amina como agentes inhibidores de hsp90 | |
| EA200400086A1 (ru) | Новые производные оксазолидинонов в качестве антибактериальных агентов | |
| PA8678901A1 (es) | Derivados de quinolina como agentes antibacteriales | |
| CO5660260A2 (es) | Derivados de benzimidazol, composiciones que los contienen, preparacion y el uso de los mismos | |
| PE20080941A1 (es) | Compuestos triciclicos como agonistas del receptor de melatonina | |
| CL2004000979A1 (es) | Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida. | |
| UY27413A1 (es) | Agonistas de la oxitocina | |
| PE20060942A1 (es) | Derivados nonadepsipeptidos acilados ii como agentes bactericidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |